Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Operating Expenses (2019 - 2025)

Historic Operating Expenses for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $29.9 million.

  • Outset Medical's Operating Expenses fell 842.46% to $29.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $113.5 million, marking a year-over-year decrease of 2532.53%. This contributed to the annual value of $113.5 million for FY2025, which is 2532.53% down from last year.
  • Latest data reveals that Outset Medical reported Operating Expenses of $29.9 million as of Q4 2025, which was down 842.46% from $27.4 million recorded in Q3 2025.
  • Over the past 5 years, Outset Medical's Operating Expenses peaked at $52.6 million during Q3 2023, and registered a low of $27.4 million during Q3 2025.
  • Moreover, its 5-year median value for Operating Expenses was $40.7 million (2022), whereas its average is $39.1 million.
  • As far as peak fluctuations go, Outset Medical's Operating Expenses soared by 8001.32% in 2021, and later plummeted by 3913.84% in 2025.
  • Outset Medical's Operating Expenses (Quarter) stood at $44.1 million in 2021, then grew by 2.21% to $45.1 million in 2022, then decreased by 0.07% to $45.1 million in 2023, then fell by 27.64% to $32.6 million in 2024, then dropped by 8.42% to $29.9 million in 2025.
  • Its Operating Expenses stands at $29.9 million for Q4 2025, versus $27.4 million for Q3 2025 and $28.7 million for Q2 2025.